Friday, November 7, 2008

New Sudden Cardiac Death Database To Save Lives, UK

A database launched today will help identify the incidence and causes of sudden cardiac death and save the lives of people who may currently be at risk from the inherited heart condition that can strike without warning, the Department of Health announced today. Continue reading ...

Wild migratory birds may be more important carriers of avian influenza viruses from continent to continent than previously thought, according to new scientific research that has important implications for highly pathogenic avian influenza virus surveillance in North America. As part of a multi-pronged research effort to understand the role of migratory birds in the transfer of avian influenza viruses between Asia and North America, scientists with the U.S. Geological Survey (USGS), in collaboration with the U.S. Fish and Wildlife Service in Alaska and the University of Tokyo, have found genetic evidence for the movement of Asian forms of avian influenza to Alaska by northern pintail ducks. Continue reading ...

Plethora Solutions Holdings PLC ("Plethora" or the "Company", AIM: PLE), the specialist developer of products for the treatment and management of urological disorders, announces that its European Phase III double-blind placebo controlled study of PSD502 for the treatment of premature ejaculation (PE) has met its three co-primary endpoints of Intra-vaginal Ejaculation Latency Time ('IELT') and Index of Premature Ejaculation ('IPE'; Ejaculatory Control and Sexual Satisfaction domains). Continue reading ...

Vermed, a manufacturer of quality cardiac monitoring and diagnostic electrodes, introduces a new line of Defibrillation Pads with features new and unique to the market. Vermed pads use a new Universal Connector System (UCS) that allows standardization of the defib pads throughout any facility. This is a tremendous step toward patient safety and industry compliance. Continue reading ...

BTG plc (LSE:BGC), the life sciences company, announces that the full results of the US phase II safety study of Varisolve® are being presented today at the American College of Phlebology (ACP) 22nd Annual Congress. The results confirm that treatment with Varisolve® in subjects with right-to-left (R-L) cardiac shunts, which may allow residual bubbles following treatment to enter the cerebral arterial circulation, does not cause cerebral injury. Continue reading ...

For most patients with chronic kidney disease (CKD), the risk of experiencing a cardiovascular related death is greater than the risk of progressing to end-stage renal disease (ESRD). Continue reading ...

Be On The Look Out For The Coliform Bacteria To Save Lives

The E. coli colifom just like many other bacteria is believed to be generally harmless to people. They are likely to be found inside human and animal intestines. However, research has it that these types of coliform bacteria may contain some dangerous strains that may in the long run cause a lot of problems to the host organism. The E. coli bacteria are said to be the main causes of cholera outbreaks and many other cases of diarrhea conditions in human beings.

For African Americans With Hypertensive Nephrosclerosis, End Stage Renal Disease Risks Exceed Risk Of Death From Heart Disease

For most patients with chronic kidney disease (CKD), the risk of experiencing a cardiovascular related death is greater than the risk of progressing to end-stage renal disease (ESRD). Read more ...

BTG plc (LSE:BGC), the life sciences company, announces that the full results of the US phase II safety study of Varisolve® are being presented today at the American College of Phlebology (ACP) 22nd Annual Congress. The results confirm that treatment with Varisolve® in subjects with right-to-left (R-L) cardiac shunts, which may allow residual bubbles following treatment to enter the cerebral arterial circulation, does not cause cerebral injury. Read more ...

Vermed, a manufacturer of quality cardiac monitoring and diagnostic electrodes, introduces a new line of Defibrillation Pads with features new and unique to the market. Vermed pads use a new Universal Connector System (UCS) that allows standardization of the defib pads throughout any facility. This is a tremendous step toward patient safety and industry compliance. Read more ...

"Because of the scarcity of available organs, the Montefiore-Einstein Heart Center is looking at new ways for heart disease patients to go on living with their own hearts. This is a paradigm shift in the way we approach the failing heart," says Daniel Goldstein, MD, Surgical Director of the heart Transplant and Mechanical Assist Device Program. On Thursday, November 13th at 7:00pm on Read more ...

The combination of health risks known as metabolic syndrome affects slightly less than a quarter of the U.S. workforce and is linked to increased absenteeism and poorer health status, reports a study in the October Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM). Read more ...

A database launched today will help identify the incidence and causes of sudden cardiac death and save the lives of people who may currently be at risk from the inherited heart condition that can strike without warning, the Department of Health announced today. Read more ...

Boston Scientific Corporation (NYSE: BSX) today announced that the first patient was enrolled in the SEPTAL CRT clinical study, sponsored by the Company's Cardiac Rhythm Management (CRM) group. The patient was enrolled in France by Prof. Christophe Leclercq MD from CHU-Hôpital Pontchaillou, Rennes. Read more ...